{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T15:22:33Z","timestamp":1726759353476},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["General Hospital Psychiatry"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.genhosppsych.2010.11.008","type":"journal-article","created":{"date-parts":[[2011,1,4]],"date-time":"2011-01-04T09:10:41Z","timestamp":1294132241000},"page":"200.e13-200.e15","source":"Crossref","is-referenced-by-count":6,"title":["Decreased thyroid function in Korean women with bipolar disorder receiving valproic acid"],"prefix":"10.1016","volume":"33","author":[{"given":"Young-Min","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Gul","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bun-Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heon-Jeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.genhosppsych.2010.11.008_bb0005","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM199512213332507","article-title":"Drugs and thyroid function","volume":"333","author":"Surks","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.genhosppsych.2010.11.008_bb0010","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1600-0404.1983.tb04569.x","article-title":"Serum thyroid hormones and blood folic acid during monotherapy with carbamazepine or valproate. A controlled study","volume":"67","author":"Bentsen","year":"1983","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.genhosppsych.2010.11.008_bb0015","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1528-1157.1985.tb05697.x","article-title":"Thyroglobulin and thyroid hormones in patients on long-term treatment with phenytoin, carbamazepine, and valproic acid","volume":"26","author":"Ericsson","year":"1985","journal-title":"Eilepsia"},{"key":"10.1016\/j.genhosppsych.2010.11.008_bb0020","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1528-1157.1978.tb04498.x","article-title":"Effects of anticonvulsant drugs on thyroid hormones in epileptic children","volume":"19","author":"Fichsel","year":"1978","journal-title":"Epilepsia"},{"key":"10.1016\/j.genhosppsych.2010.11.008_bb0025","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1046\/j.1528-1157.2001.042007930.x","article-title":"Thyroid function in men taking carbamazepine, oxcarbazepine, or valproate for epilepsy","volume":"42","author":"Isoj\u00e4rvi","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.genhosppsych.2010.11.008_bb0030","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/1531-8249(199904)45:4<444::AID-ANA5>3.0.CO;2-6","article-title":"Valproate-induced hyperandrogenism during pubertal maturation in girls with epilepsy","volume":"45","author":"Vainionp\u00e4\u00e4","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.genhosppsych.2010.11.008_bb0035","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0887-8994(01)00279-X","article-title":"Thyroid hormones in epileptic children receiving carbamazepine and valproic acid","volume":"25","author":"Verrotti","year":"2001","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.genhosppsych.2010.11.008_bb0040","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJM199311043291904","article-title":"Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy","volume":"329","author":"Isoj\u00e4rvi","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.genhosppsych.2010.11.008_bb0045","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1542\/peds.103.3.588","article-title":"The effects of valproate, carbamazepine, and oxcarbazepine on growth and sexual maturation in girls with epilepsy","volume":"103","author":"R\u00e4tty\u00e4","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.genhosppsych.2010.11.008_bb0050","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.0013-9580.2004.26003.x","article-title":"Thyroid function in girls with epilepsy with carbamazepine, oxcarbazepine, or valproate monotherapy and after withdrawal of medication","volume":"45","author":"Vainionp\u00e4\u00e4","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.genhosppsych.2010.11.008_bb0055","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1210\/jcem-37-2-308","article-title":"Effects of phenobarbital on thyroxine and triiodothyronine kinetics in Graves' disease","volume":"37","author":"Cavalieri","year":"1973","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.genhosppsych.2010.11.008_bb0060","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1172\/JCI105831","article-title":"Increased thyroxine turnover and thyroidal function after stimulation of hepatocellular binding of thyroxine by phenobarbital","volume":"47","author":"Openheimer","year":"1968","journal-title":"J Clin Invest"},{"key":"10.1016\/j.genhosppsych.2010.11.008_bb0065","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/archneur.1989.00520470029021","article-title":"Thyroid function in epileptic patients treated with carbamazepine","volume":"46","author":"Isoj\u00e4rvi","year":"1989","journal-title":"Arch Neurol"},{"key":"10.1016\/j.genhosppsych.2010.11.008_bb0070","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1600-0404.1981.tb00754.x","article-title":"Influence of carbamazepine on serum thyroxine and triiodothyronine in patients with epilepsy","volume":"63","author":"Strandjord","year":"1981","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.genhosppsych.2010.11.008_bb0075","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF02784425","article-title":"Zinc sulfate supplementation improves thyroid function in hypozincemic Down children","volume":"67","author":"Bucci","year":"1999","journal-title":"Biol Trace Elem Res"},{"key":"10.1016\/j.genhosppsych.2010.11.008_bb0080","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-2007-973560","article-title":"Altered antioxidant enzyme activities in children with a serious adverse experience related to valproic acid therapy","volume":"29","author":"Graf","year":"1998","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.genhosppsych.2010.11.008_bb0085","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1385\/BTER:77:3:199","article-title":"Selenium deficiency and hypothyroidism: a new etiology in the differential diagnosis of hypothyroidism in children","volume":"77","author":"Pizzulli","year":"2000","journal-title":"Biol Trace Elem Res"},{"key":"10.1016\/j.genhosppsych.2010.11.008_bb0090","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/pgmj.63.744.841","article-title":"The effective evaluation of thyroid status in patients on phenytoin, carbamazepine or sodium valproate attending an epilepsy clinic","volume":"63","author":"Connacher","year":"1987","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.genhosppsych.2010.11.008_bb0095","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1111\/j.1528-1157.1999.tb01595.x","article-title":"Long-term treatment of children with epilepsy with valproate or carbamazepine may cause subclinical hypothyroidism","volume":"40","author":"Eir\u00eds-Pu\u00f1al","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.genhosppsych.2010.11.008_bb0100","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1528-1157.1992.tb02297.x","article-title":"Thyroid function with antiepileptic drugs","volume":"33","author":"Isoj\u00e4rvi","year":"1992","journal-title":"Epilepsia"},{"key":"10.1016\/j.genhosppsych.2010.11.008_bb0105","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jpeds.2007.02.046","article-title":"Risk factors for development of subclinical hypothyroidism during valproic acid therapy","volume":"151","author":"Mikati","year":"2007","journal-title":"J Pediatr"},{"key":"10.1016\/j.genhosppsych.2010.11.008_bb0110","first-page":"119","article-title":"Changes of thyroid hormone levels in epileptic patients","volume":"14","author":"Zhu","year":"1994","journal-title":"J Tongji Med Univ"},{"key":"10.1016\/j.genhosppsych.2010.11.008_bb0115","series-title":"Seroquel (Quetiapine Fumarate) Product Monograph. Rev 01\/04","year":"2004"},{"issue":"10","key":"10.1016\/j.genhosppsych.2010.11.008_bb0120","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.4088\/JCP.v66n1019e","article-title":"Thyroid dysfunction during treatment with atypical antipsychotics","volume":"66","author":"Greenspan","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.genhosppsych.2010.11.008_bb0125","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1345\/aph.19186","article-title":"Possible hypothyroidism associated with quetiapine","volume":"34","author":"Feret","year":"2000","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.genhosppsych.2010.11.008_bb0130","first-page":"57","article-title":"Quetiapine-induced hypothyroidism","volume":"30","author":"Ramaswamy","year":"2005","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.genhosppsych.2010.11.008_bb0135","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/01.jcp.0000203227.56494.ff","article-title":"Hypothyroidism induced by quetiapine: a case report","volume":"26","author":"Liappas","year":"2006","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.genhosppsych.2010.11.008_bb0140","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/WNF.0b013e3181a8cbcc","article-title":"Can quetiapine-induced hypothyroidism be reversible without quetiapine discontinuation?","volume":"32","author":"Kontaxakis","year":"2009","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.genhosppsych.2010.11.008_bb0145","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4088\/JCP.v66n0111","article-title":"Thyroid function in treatment-resistant schizophrenia patients treated with quetiapine, risperidone, or fluphenazine","volume":"66","author":"Kelly","year":"2005","journal-title":"J Clin Psychiatry"}],"container-title":["General Hospital Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016383431000246X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016383431000246X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T20:54:15Z","timestamp":1544043255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016383431000246X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S016383431000246X"],"URL":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2010.11.008","relation":{},"ISSN":["0163-8343"],"issn-type":[{"value":"0163-8343","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}